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2011). Sialorphin is a peptide synthesized predominantly 
in the submandibular gland and prostate of adult rats in 
response to androgen steroids, and is released locally and 
systemically in response to stress (Rougeot et  al. 2003). 
Sialorphin exhibits a potent analgesic activity and plays a 
crucial role in the control of social behavior, pain percep-
tion and in sexual behavior (Davies et al. 2007; Messaoudi 
et al. 2004; Rougeot et al. 2003).
The metal ions such as Cu(II), Ni(II), and Zn(II) are 
essential and beneficial elements in mammalian nutrition, 
are required in a number of enzymatic reactions and can be 
important regulators of activity of many peptides (Barnea 
1989; Cummins and O’Connor 1998; Gerega et al. 1988).
Copper ions play an important role in the progression of 
neurodegenerative diseases (Migliorini et al. 2014; Valen-
sin et al. 2016), affect the development and progression of 
different cancers (Khanna et al. 2013), exhibit anti-inflam-
matory effects (Lewis 1984), are essential for bone integrity 
and elasticity (Sierpinska et al. 2014), influence tooth dem-
ineralization and remineralization (Abdullah et  al. 2006; 
Brookes et al. 2003) as well as aroma perception by affect-
ing volatility of aroma compounds in the mouth through 
interaction with salivary components, especially proteins 
(Hong et  al. 2006). Human body is provided in various 
complicated mechanisms involving interactions with pro-
teins and other molecules that make copper available dur-
ing its deficiency, as well as enable elimination of excessive 
copper through absorption, transport, distribution, storage 
and excretion. Any failure of the copper homeostasis results 
inevitably in severe diseases. Elevated levels of salivary 
copper are observed in patients with oral submucous fibro-
sis, oral leukoplakia and oral cancer (Ayinampudi and Nar-
simhan 2012; Trivedy et al. 1999, 2000, 2001). The copper 
deficiency is associated with a decreased bone strength and 
Abstract Three novel analogues of salivary peptides as 
sialorphin (QHNPR) and opiorphin (QRFSR) were synthe-
sized by the solid-phase method. The sequences of these 
ligands were following: AHNPR, QANPR and QRFPR. 
The aim of our work was investigation in what way some 
structural modifications may impact on coordination abili-
ties of studied peptides. In this work we presented the inter-
action of pentapeptides with copper(II) ions in wide range 
of pH. To determine the coordination model of ligands 
there were carried out several studies by spectroscopy 
(UV–Vis, CD) methods and potentiometric measurements.
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Introduction
Human opiorphin (QRFSR) and rat sialorphin (QHNPR) 
are natural inhibitors of enkephalin catabolism. Opiorphin 
was identified in human saliva and it showed beneficial 
effects in pain management, antidepressant-like actions 
as well as in involvement in colonic motility and erectile 
physiology (Davies 2009; Thanawala et al. 2008; Tian et al. 
2009; Tong et  al. 2008; Wisner et  al. 2006; Yang et  al. 
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deterioration of bone quality leading to osteoporotic defects 
(Medeiros et al. 1997).
In this study, we present the synthesis of some ana-
logues of sialorphin to investigate in what way some struc-
tural modification may have an impact on coordination 
abilities of the peptides. We present the interaction of new 
pentapeptides with Cu(II) ions over a wide pH range. To 
determine the coordination model of ligands, a series of 
measurements using the spectroscopic (UV–Vis, CD) and 
potentiometric techniques has been performed.
Experimental
Peptide Synthesis and Purification
All of the peptides were synthesized on a solid-phase 
method using standard Fmoc procedures on a 2-chlo-
rotrityl chloride resin (loading 0.3–0.9 mmol/g, 1% DVB, 
200–400 mesh, Orpegen Peptide Chemicals GmbH, Heide-
berg, Germany). N-α-protected amino acids, and reagents 
used for the solid-phase synthesis were obtained from Iris 
Biotech GmbH (Marktredwitz, Germany). Peptides chains 
were elongated in the consecutive cycles of deprotection 
and coupling. Two deprotection steps using 20% piperi-
dine in dimethylformamide (DMF) (5 and 15  min) were 
performed. The coupling reactions were carried out with a 
threefold molar excess of the protected amino acid (Fmoc-
AA) dissolved in DMF/dichloromethane (DCM) using 
N,N′-diisopropylcarbodiimide (DIC) and N-hydroxyben-
zotriazole (HOBt) for 2  h (Fmoc-AA:HOBt:DIC, 1:1:1). 
The completeness of each coupling step was monitored by 
the chloranil test. The peptides were cleaved from the resin 
and the protecting groups were removed in one step using a 
mixture of TFA/triisopropylsilane/H2O (95:2.5:2.5, v/v/v). 
The cleaved peptides were precipitated with cold diethyl 
ether and lyophilized.
The peptides were purified using the RP-HPLC on a 
Kromasil C8 column (8 × 250 mm, 100 Å pore size, 5 µm 
particle size) with linear gradient 2–40% of acetonitrile in 
0.1% TFA for 30 min with a flow rate of 10 mL/min. The 
purity of the peptides was checked on a Beckman HPLC 
controlled by Lp-Chrom system. Fractions containing the 
pure peptides (>98%) were pooled and lyophilized. The 
mass spectrometry analysis were carried out on a MALDI-
TOF MS. Physicochemical characteristics of all synthe-
sized peptides are presented in Table 1.
Potentiometry Measurements
The potentiometry titrations were conducted on a 
MOLSPIN pH-meter system, using a Mettler Toledo 
 InLab®Micro combined electrode. The pH-meter system 
was calibrated by triple titration of hydrogen ion (HCl) 
before each measurement. The potentiometric experiments 
were performed in argon atmosphere over the pH range 
3.0–11.5 at 298 K. The ligands were dissolved in HCl/KCl 
where pH = 3.0 and I = 0.1 M (KCl), the ligands concentra-
tion were 1 × 10−3 M. The accurate concentration of ligands 
solutions were determined by Gran method. The samples of 
each titration were prepared by adding equimolar amounts 
of  CuCl2 solutions. Titration volume were 1–1.5  ml and 
alkali (c(KOH) ~0.1  M) was added from a 0.250  ml 
micrometer syringe. The stability constants for the proton 
(βi(H)) and Cu(II) complexes (β(CupHqLr)) were calculated 
by HYPERQUAD 2008 (written by Peter Gans, Protonic 
Software) and SUPERQUAD computer programs (Gans 
et al. 1985, 1996). The protonation constants of ligands is 
determined by: βi = [HiL]/[H+]i[L] and the equilibrium of 
complex stability: βpqr = [MpHqLr]/[M]p[H]q[L]r. Standard 
deviations were computed by these both programs and refer 
to random errors only.
Spectroscopy Measurements (UV–Vis, CD)
All  spectroscopic measurements were carried out at 
298 K. The solutions of samples were prepared in simi-
lar way like samples used in pH-metric titration. The pH 
Table 1  Physicochemical 
characteristics of investigated 
peptides
a Linear gradient from 2 to 40% of [B] in [A] for 15 min, flow rate of 1.5 mL/min, Kromasil C8 column 
(5 μm, 4.6 × 250 mm), where [A] is 0.1% TFA in  H2O and [B] is 0.1% TFA in acetonitrile
b Linear gradient from 2 to 60% of [B] in [A] for 15 min, flow rate of 1.5 mL/min, Kromasil C8 column 
(5 μm, 4.6 × 250 mm), where [A] is 0.1% TFA in  H2O and [B] is 0.1% TFA in acetonitrile
Peptide Sequence Formula HPLC  Rt (min) [M]+calc. [M + H]+found
Opiorphin QRFSR C29H48N12O8 6.7a 692.4 693.3
Sialorphin QHNPR C26H42N12O8 5.5a 650.3 651.2
P1 QRFPR C31H50N12O7 7.87b 702.4 703.1
P2 AHNPR C24H39N11O7 5.37b 593.29 594.8
P3 QANPR C23H40N10O8 5.21b 584.29 585.0
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of the samples were determined by adding small quantity 
of concentrated solutions of KOH. The UV–Vis absorp-
tion spectra of complexes were recorded on Varian Carry 
50 Bio spectrophotometer. All spectra were collected in 
quartz cells with 1 cm path length and spectral range was 
230–800 nm. For each spectra were calculated the molar 
extinction coefficients [ε  (M−1  cm−1)] at a wavelength 
of maximum absorption. The circular dichroism (CD) 
spectra were recorded on a magnetic circular spectrom-
eter JASCO J-1500. The measurements were conducted 
in 0.5 cm cuvettes in the range 240–800 nm with 0.1 nm 
resolution. The measurements were carried out in an inert 
gas atmosphere  (N2). The CD spectral data were recalcu-
lated to the molar ellipticity [ε  (M−1 cm−1)].
Results and Discussion
The presented manuscript shows the binding abilities of 
three novel analogues of saliva pentapeptides: opiorphin 
and sialorphin (Scheme  1a, b). The characteristic feature 
of these ligands is the presence the glutamate amino acid 
residue in the position 1 of the peptide chain. Moreover 
sialorphin has His and Pro moieties located at position 2 
and 4 of the peptide chain (Scheme 1b). These two residues 
significantly influence the process of the metal ion binding 
(Kozłowski et al. 1999; Pettit et al. 1985; Sovago and Osz 
2006; Sovago et al. 2016).
The modification of the opiorphin has been performed 
by the insertion of proline residue instead of the serine 














































































































P1 – QRFPR P2 - AHNPR P3 - QANPR
c) d) e)
Scheme 1  The full protonated structure of: a opiorphin, b sialorphin, and their analogues: c P1–QRFPR, d P2–AHNPR, e P3–QANPR
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have been created by the insertion of alanine residue instead 
of Gln-1 (P2, Scheme 1d) or His-2 (P3, Scheme 1e) in the 
sialorphin sequence. The detailed analysis of the results 
obtained for these analogues in comparison to the results 
for the parent peptide allows to characterize the influence 
of the specific amino acid resides as Gln, His, Pro or Asn 
on the coordination abilities of two selected saliva peptides.
The first step of the presented studies is the analysis of 
the results obtained for the analogue of opiorphin (P1). The 
acid-base properties as well as the stabilities constants of 
Table 2  Protonation constants of P1–QRFPR and stability constants with the spectroscopic parameters for its Cu(II) complexes at T = 293 K, 
I = 0.1 M (KCl)
P1
Species logβ pK
HL 11.34 ± 0.04 11.34 (Arg)
H2L 18.42 ± 0.05 7.08 (-NH2)
H3L 21.53 ± 0.05 3.11 (-COO−)
Cu(II) complexes
Species/binding model logβ pK UV–Vis CD
λ(nm) ε(M−1 cm−1) λ(nm) ε(M−1 cm−1)
CuHL {NH2,  3H2O} 16.42 ± 0.08 680 47 315 0.25
CuL {NH2,  N−am,  2H2O} 10.71 ± 0.04 7.33 640 89 566 −0.41
315 0.89
268 −1.22
CuH−1L {NH2,  2N−am,  H2O} 3.87 ± 0.05 9.39 573 138 569 −0.85
315 1.02
275 −1.03
CuH−2L {NH2,  2N−am,  OH−} −5.64 ± 0.07 11.14 573 134 562 −0.85
315 0.97
270 −1.75
CuH− 3L {NH2,  2N−am,  OH−} −17.03 ± 0.11 579 112 545 −0.80
315 0.63
270 −3.43









































Opiorphin - QRFSRa b
Fig. 1  a The species distribution curve of formed Cu(II) complexes 
in dependence on pH for P1 (solid line) and opiorphin (dashed line). 
b The diagram for competitive binding of Cu(II) ions by P1 (solid 
line) and opiorphin (dashed line) ligands. The opiorphin:Cu(II):P1 
molar ratio is 1:1:1, C = 1 × 10−3M
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formed complexes and the spectral abilities are presented 
in Table 2.
The ligand P1 forms five types of complexes as its par-
ent peptide (Fig. 1a; Table 1). The metal ion binding by P1 
starts around pH 4 by the formation of the CuHL species, 
which achieves its highest concentration at pH 5.5 (Fig. 1a). 
The value of logβ* = 5.08, were logβ* = logβCuHL − logβHL, 
is comparable to stabilities calculated for the complexes 
with the N terminal amino group involved in Cu(II) bind-
ing (Prenesti et al. 1999). Moreover, the λmax for d-d transi-
tion at 680 nm confirms the involvement only one nitrogen 
donor in metal ion binding (Prenesti et al. 2006).
Afterwards, with the increase of pH, the involvement 
of the first and the second amide takes place and forma-
tion of the species with the {NH2,  N−am, 2×H2O}, {NH2, 
2×N−am,  H2O}  (Scheme  2) donor atoms in the plane is 
observed, consecutively. The location of the λmax for d–d 
transitions at CuL640 nm and CuH−1L573 nm are in good 
agreement with the theoretical λmax = 650, 576  nm cal-
culated for proposed donor sets (Billo 1974; Prenesti 
et al. 1999). Moreover, the involvement of the N terminal 
amino as well as amide donors in Cu(II) coordination is 
supported by presence of one negative and one positive 
CT bands at 270 and 320 nm (Table 2), consecutively. Up 
to pH 7, the process of Cu(II) binding by the unmodified 
and modified opiorphin is carried out in the same manner. 
Nevertheless, the insertion of proline in position 4 pro-
motes the formation of the species with {NH2,  2xN−am, 
 H2O} coordination. Above last to complexes appear in 
the investigated system:  CuH−2L and  CuH−3L, and this 
P1 – CuL – {NH2, N
-
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Scheme 2  The schematic structures of the Cu(II) complexes existing in the salivary range of pH (6.5–7.5) in the system with ligands P1, P2 and 
P3. The water molecules were omitted to more clarity
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Table 3  Protonation constants of peptides P2–AHNPR and P3–QANPR and stability constants with the spectroscopic parameters for Cu(II) 
complexes at T = 298 K, I = 0.1 M (KCl)
P2
Species logβ pK
HL ∼11.91 ± 0.09 ∼11.91 (Arg)
H2L 19.83 ± 0.09 7.92 (–NH2)
H3L 26.01 ± 0.10 6.19  (NIm)
H4L 29.11 ± 0.10 3.10 (–COO−)
Cu(II) complexes
Species/binding model logβ pK UV–Vis CD
λ (nm) ε  (M−1 cm−1) λ (nm) ε  (M−1 cm−1)
CuH2L {NH2,  3H2O} 25.22 ± 0.04 – – – –














HL ∼11.19 ± 0.04 ∼11.19 (Arg)
H2L 18.62 ± 0.05 7.43 (–NH2)
H3L 21.98 ± 0.06 3.36 (–COO−)
Cu(II) complexes
Species/binding model logβ pK UV–Vis CD
λ (nm) ε  (M−1 cm−1) λ (nm) ε  (M−1 cm−1)
CuHL {NH2,  3H2O} 16.74 ± 0.03 678 15 – –
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process does not influences significantly the spectral abil-
ities of the system (Table 2).
As it was mentioned above in the case of opiorphin the 
formation next two species is observed at significantly 
lower range of pH. Moreover the unmodified opiorphin, 
involves third amide donor in Cu(II) binding and forms the 
species with the {NH2,  3xN−am} binding manner (Kotynia 
et al. 2010). This ability is associated with the absence of 
the Pro-4 in the peptide backbone. The proline is the amino 
acid residue which strongly influences the binding abil-
ity of the peptide. When proline is present in the peptide 
chain starting from the position 2, it effectively prevents 
binding of the subsequent amide donors (Bataille et  al. 
1984; Formicka-Kozlowska et  al. 1981; Kozłowski et  al. 
1999). Owing to this fact and any significant changes in 
the spectral abilities of the system above pH 9,5, the for-
mation of the  CuH−2L and  CuH−3L complexes may be 
assigned to proton dissociation form the metal bound water 
molecule(Holm et al. 1996; Jakab et al. 2008; Kamysz et al. 
2013) and guanidyl group of the side chain of arginine moi-
ety (Fitch et al. 2015; Holm et al. 1996; Matera et al. 2008).
As it was mentioned, the insertion of the proline in the 
fourth position of the peptide backbone effectively pre-
vents the involvement of the subsequent amide donor, 
however due to this fact, the system with the ligand P1 is 
more specific and selective in comparison to the unmodi-
fied opiorphin.
The investigations of the coordination abilities of two 
new analogues of sialorphin: P2 and P3 (Scheme  1 d, e) 
were the next step of our studies. The modification in the 
case of the first sialorphin analogue (P2) consisted in the 
replacement of Gln-1 by alanine moiety and it does not 
influences the binding abilities of P2. It forms the same 
type of dominant complexes as unmodified ligand (Kamysz 
et al. 2013). The species CuL dominating at physiological 
range of pH is the characteristic complex for His-2 peptides 
(Kozłowski et  al. 1999) with three nitrogen donors from: 
N terminal amino group, first amide and imidazole ring for 
His-2 moiety (Scheme 2). The presence of these donors in 
the coordination sphere of Cu(II) ion is supported by the CT 
transitions at: 340 and 263 nm (Table 3) in CD spectrum. 
Moreover the location of the d–d band at 600 nm (Table 3) 
is almost the same as theoretical λmax = 599 nm, calculated 
for the –NH2,  N−am,  NIm,  H2O chromophores, what sup-
ports the postulated coordination mode. The appearance of 
the final species significantly influences the spectral abili-
ties as the red shift of the λmax d–d 600 nm → 528 nm what 
suggests four nitrogen donors in the square plane symmetry 














Fig. 2  The diagram for competitive binding of Cu(II) ions by 
P2 and sialorphin. The sialorphin:Cu(II):P1 molar ratio is 1:1:1, 
 Cl = 1 × 10−3M











































Fig. 3  a The species distribution curve of formed Cu(II) complexes in dependence on pH for P3 (solid line) and P1 (dashed line). b The dia-
gram for competitive binding of Cu(II) ions by P3 (solid line) and P1 (dashed line) ligands. The P3:Cu(II):P1 molar ratio is 1:1:1, C = 1 × 10−3M
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(Casolaro et al. 1999; Marchewka et al. 2002). The forma-
tion such complex is possible when: the N terminal amino 
group, two amides and amide form the side chain if Asn-3 
are bound to Cu(II). The same type of the species was 
found for the sialorphin (Kamysz et al. 2013).
As it was presented above, the modification does not 
influences significantly the binding abilities of the peptide 
however the efficiency in Cu(II) binding changes (Fig. 2). 
Below pH 8, the P2 is around 20% less effective in Cu(II) 
binding however its efficiency significantly increases above 
this pH. It is probably caused by the steric changes induced 
less developed side chain of alanine than glutamine.
The interesting results have been obtained for the third 
from investigated peptide P3 (Scheme  1e) consisting ala-
nine in position 2 instead of His moiety. Moreover, due to 
the presence of Pro-4 residue in the peptide chain it can be 
also assigned as the analogue of P1. The comparison of the 
coordination abilities between P3 and P1 and sialorphin, 
shows that P3 has higher similarity in copper coordination 
as P1 than sialorphin.
P3 starts Cu(II) binding by formation of the CuHL spe-
cies with metal ion anchored by the N terminal amino 
group (Fig. 3a), as it was found in a case of P1. Then with 
increase of pH simultaneous dissociation of two protons 
take place and the  CuH−1L appears in the system. This 
process is correlated with the involvement of the next two 
nitrogen donors binding to copper ion, what is confirmed 
by the spectroscopic results obtained for the  CuH−1L spe-
cies (Table 3, Scheme 2).
The presence of CT transitions at 311, 276 and 243 nm 
(Table 3) in CD spectrum confirm the involvement of the 
amido and amino donors in copper (II) binding. Moreover, 
the location of d–d supports involvement of three nitrogen 
donors in copper binding. Owing to these facts, the dis-
cussed complex can be characterized by the {NH2, 2×N−am, 
 H2O} binding mode and it dominates in salivary range of 
pH as in a case of P1 (Scheme 2).
With increase of pH last two species exist in the system. 
First of them is the  CuH−2L, which achieves its highest 
concentration at pH 9.5 (Fig. 3a). The spectroscopic param-
eters of the system at pH 9.5 do not change significantly 
(Table  3) what may support the proton dissociation form 
the metal bound water molecule (Holm et al. 1996; Jakab 
et  al. 2008; Kamysz et  al. 2013). The spectral abilities of 
the investigated system dramatically change above pH 10, 
in which the dominant is the  CuH−3L species. The most of 
all the shift of λmax to 520 nm (Table 3) strongly support 
the involvement of the fourth nitrogen in copper binding 
and formation of the complex with square planar symmetry.
Based on the peptide structure and the previous results 
for sialorphin (Kamysz et al. 2013), there is only one pos-
sibility to involve fourth nitrogen in Cu(II) coordination: 
Scheme 3  The schematic 
structures of the final Cu(II) 
complexes existing in basic pH 
in the system with ligands P1, 
P2 and P3
P1 – CuH-3L – {NH2, 2N
-
am, OH
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it is the amide nitrogen from the side chain of Asn-3 resi-
due (Scheme 3). The same process was also observed in 
a case of P2 (Scheme 3) as well as unmodified sialorphin 
(Kamysz et al. 2013).
Despite the fact, that both peptides form the same type 
of dominant complexes, except the last one, they show 
different efficiency in metal binding (Fig.  3b). Starting 
already from pH 5 the P3 is getting to be significantly 
more effective in copper binding as the P2. This differ-
ence may be caused by the fact that the P3 has alanine 
residue at position 2 of the peptide backbone. Alanine is 
the amino acid with simpler side chain in comparison to 
arginine, which is present in the second position of the 
P1 peptide chain and the simultaneously involvement of 
two amide donors and formation of the more stable spe-
cies with the {NH2,  2N−am} is observed already at pH 5 
in contrast to P1 (Fig. 3a).
Conclusions
In the presented manuscript we have characterized coor-
dination abilities of new analogues of the saliva peptides 
(opiorphin and sialorhin) toward Cu(II) ions. The detailed 
analysis of the results obtained for these analogues in 
comparison to the results for the parent peptides allowed 
to characterize the influence of the specific amino acid 
resides as Gln, His, Pro or Asn on the coordination abil-
ities of two selected saliva peptides as well as the effi-
ciency in metal binding. The knowledge on coordination 
abilities of salivary peptides and their analogues by cop-
per ions is crucial for a rational drug design of new thera-
peutic agents that could be involved in the regulation of 
the level of copper ions.
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